Literature DB >> 3602497

Risk homeostasis theory and traffic accident data.

L Evans.   

Abstract

The risk homeostasis theory posits, in essence, that a control mechanism analogous to the thermal homeostatic system in warm-blooded animals tends to keep risk per unit time constant, and, as a consequence, the number of traffic accidents per unit time of driving also tends to remain constant, essentially independent of changes in the traffic safety system. It is the purpose of the present research to examine the validity of this claim using a wide variety of traffic accident data. All the data examined are found to be incompatible with the risk homeostasis theory. The only specific field accident data offered in the literature to support the risk homeostasis theory are found to, in fact, refute the theory. The accident data provide evidence that a rich variety of user responses occur. While it is possible for users to collectively respond in such a way that safety benefits are completely cancelled, such a response is not particularly common; it is certainly not universally occurring, as suggested by the risk homeostasis theory. It is concluded that the risk homeostasis theory should be rejected because there is no convincing evidence supporting it and much evidence refuting it.

Mesh:

Year:  1986        PMID: 3602497     DOI: 10.1111/j.1539-6924.1986.tb00196.x

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  3 in total

1.  Risky business: safety regulations, risks compensation, and individual behavior.

Authors:  J Hedlund
Journal:  Inj Prev       Date:  2000-06       Impact factor: 2.399

2.  Influence of safety gear on parental perceptions of injury risk and tolerance or children's risk taking.

Authors:  B A Morrongiello; K Major
Journal:  Inj Prev       Date:  2002-03       Impact factor: 2.399

3.  Does a perception of increased blood safety mean increased blood transfusion? An assessment of the risk compensation theory in Canada.

Authors:  Mo Amin; Kumanan Wilson; Alan Tinmouth; Paul Hébert
Journal:  BMC Public Health       Date:  2004-06-07       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.